Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Peloruside, laulimalide, and noscapine interactions with beta-tubulin.Gajewski, Melissa M ; Alisaraie, Laleh ; Tuszynski, Jack A Gajewski, Melissa M (correspondence author) ; Gajewski, Melissa M (record owner) November 2012Pharmaceutical research, Vol.29(11), pp.2985-2993 [Peer Reviewed Journal]Full text available |
2 |
Material Type: Article
|
![]() |
Elucidating the signal responses of multi-parametric surface plasmon resonance living cell sensing: a comparison between optical modeling and drug-MDCKII cell interaction measurements.Viitala, Tapani ; Granqvist, Niko ; Hallila, Susanna ; Raviña, Manuela ; Yliperttula, Marjo Viitala, Tapani (correspondence author) ; Viitala, Tapani (record owner)PloS one, 2013, Vol.8(8), p.e72192 [Peer Reviewed Journal]Full text available |
3 |
Material Type: Article
|
![]() |
Identification of PPARgamma partial agonists of natural origin (I): development of a virtual screening procedure and in vitro validation.Guasch, Laura ; Sala, Esther ; Castell-Auví, Anna ; Cedó, Lidia ; Liedl, Klaus R ; Wolber, Gerhard ; Muehlbacher, Markus ; Mulero, Miquel ; Pinent, Montserrat ; Ardévol, Anna ; Valls, Cristina ; Pujadas, Gerard ; Garcia-Vallvé, Santiago Guasch, Laura (correspondence author) ; Guasch, Laura (record owner)PloS one, 2012, Vol.7(11), p.e50816 [Peer Reviewed Journal]Full text available |
4 |
Material Type: Article
|
![]() |
Plasmin inhibitors prevent leukocyte accumulation and remodeling events in the postischemic microvasculature.Reichel, Christoph A ; Lerchenberger, Max ; Uhl, Bernd ; Rehberg, Markus ; Berberich, Nina ; Zahler, Stefan ; Wymann, Matthias P ; Krombach, Fritz Reichel, Christoph A (correspondence author) ; Reichel, Christoph A (record owner)PloS one, February 22, 2011, Vol.6(2), p.e17229 [Peer Reviewed Journal]Full text available |
5 |
Material Type: Article
|
![]() |
Oral bioavailability of new drug leads is a challenge for pharmaceutical scientists.Chung, Suk-Jae Chung, Suk-Jae (correspondence author) ; Chung, Suk-Jae (record owner)Archives of pharmacal research, May 2010, Vol.33(5), p.645 [Peer Reviewed Journal]Full text available |
6 |
Material Type: Article
|
![]() |
Application of ED-optimality to screening experiments for analgesic compounds in an experimental model of neuropathic pain.Taneja, A ; Nyberg, J ; de Lange, E C M ; Danhof, M ; Della Pasqua, O Taneja, A (correspondence author) ; Taneja, A (record owner)Journal of pharmacokinetics and pharmacodynamics, December 2012, Vol.39(6), pp.673-681 [Peer Reviewed Journal]Full text available |
7 |
Material Type: Article
|
![]() |
Immunogenicity of therapeutic proteins: the use of animal models.Brinks, Vera ; Jiskoot, Wim ; Schellekens, Huub Brinks, Vera (correspondence author) ; Brinks, Vera (record owner)Pharmaceutical research, October 2011, Vol.28(10), pp.2379-2385 [Peer Reviewed Journal]Full text available |
8 |
Material Type: Article
|
![]() |
N-acetylcysteine attenuates hexavalent chromium-induced hypersensitivity through inhibition of cell death, ROS-related signaling and cytokine expression.Lee, Yu-Hsuan ; Su, Shih-Bin ; Huang, Chien-Cheng ; Sheu, Hamm-Ming ; Tsai, Jui-Chen ; Lin, Chia-Ho ; Wang, Ying-Jan ; Wang, Bour-Jr Lee, Yu-Hsuan (correspondence author) ; Lee, Yu-Hsuan (record owner)PloS one, 2014, Vol.9(9), p.e108317 [Peer Reviewed Journal]Full text available |
9 |
Material Type: Article
|
![]() |
Effects of Silicon vs. Hydroxytyrosol-Enriched Restructured Pork on Liver Oxidation Status of Aged Rats Fed High-Saturated/High-Cholesterol Diets.Santos-López, Jorge A ; Garcimartín, Alba ; Merino, Pinar ; López-Oliva, M Elvira ; Bastida, Sara ; Benedí, Juana ; Sánchez-Muniz, Francisco J Santos-López, Jorge A (correspondence author) ; Santos-López, Jorge A (record owner)PloS one, 2016, Vol.11(1), p.e0147469 [Peer Reviewed Journal]Full text available |
10 |
Material Type: Article
|
![]() |
Preclinical pharmacokinetic and pharmacodynamic evaluation of novel anticancer agents, ON01910.Na (Rigosertib, Estybon™) and ON013105, for brain tumor chemotherapy.Nuthalapati, Silpa ; Zhou, Qingyu ; Guo, Ping ; Lv, Hua ; Cosenza, Stephen ; Reddy, M V Ramana ; Reddy, E Premkumar ; Gallo, James M Nuthalapati, Silpa (correspondence author) ; Nuthalapati, Silpa (record owner)Pharmaceutical research, September 2012, Vol.29(9), pp.2499-2511 [Peer Reviewed Journal]Full text available |